The company is in a robust financial situation considering its net cash and margin position.
The stock, which is currently worth 2025 to 0.38 times its sales, is clearly overvalued in comparison with peers.
The company has a low valuation given the cash flows generated by its activity.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company has insufficient levels of profitability.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Over the past four months, analysts' average price target has been revised downwards significantly.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.